NASDAQ : FEMY

Femasys Inc. — Company profile

Healthcare · Medical Instruments & Supplies · United States

Last price 1.37 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 11.47M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women’s reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women’s healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Details

NameFemasys Inc.
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees54
Founded2004
Ipo Date2021-06-18
CeoKathy Lee-Sepsick
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
Ipo Price13.00
IsinUS31447E2046
Cusip31447E204
Cik1339005
Sic3841
Stock TypeCommon Stock

Key executives

NameTitle
Kathy Lee-Sepsick M.B.A.Founder, President, Chief Executive Officer and Director
Dov ElefantChief Financial Officer
John CanningChief Operating Officer
Jeremy Alexander Sipos M.S.Chief Technology Officer
Dr. James H. Liu M.D.Chief Medical Officer
Dr. Jeffrey Gerald MifekChief Clinical and Regulatory Affairs Officer

Contact

Address3950 Johns Creek Court, Suite 100, Suwanee, Georgia 30024, United States
Phone770 500 3910
Websitehttps://femasys.com